We outline the market outlook for digital twins and biosimulations in clinical research, pharma, and healthcare — from investment trends, to leading companies, to recommendations for players in the space.
What are digital twins and biosimulations?
Digital twins and biosimulations use model-based simulations to enable partially or fully virtual clinical trials by simulating versions of living humans.
In this case, digital twins are virtual models of patients. Using a variety of data sources, such as electronic health record (EHR) and claims data, digital twins can estimate outcomes for patient populations in clinical trials. Digital twins integrate simulation tools that help pharmaceutical companies optimize the complete product lifecycle, from research to production.
